+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biologics Safety Testing - Global Market Trajectory & Analytics

  • PDF Icon


  • 241 Pages
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139460
Global Biologics Safety Testing Market to Reach $3.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Biologics Safety Testing estimated at US$1.9 Billion in the year 2020, is projected to reach a revised size of US$3.3 Billion by 2027, growing at a CAGR of 8.5% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 7.8% CAGR and reach US$963.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Kits & Reagents segment is readjusted to a revised 9.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $556.7 Million, While China is Forecast to Grow at 8% CAGR

The Biologics Safety Testing market in the U.S. is estimated at US$556.7 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$582.5 Million by the year 2027 trailing a CAGR of 8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.9% and 7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7% CAGR.

Services Segment to Record 8.4% CAGR

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 8.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$344.8 Million in the year 2020 will reach a projected size of US$609 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$387.8 Million by the year 2027.

Select Competitors (Total 46 Featured):
  • Avance Biosciences Inc.
  • Charles River Laboratories International, Inc.
  • Cytovance Biologics
  • Eurofins Scientific SE
  • Lonza Group AG
  • Merck KgaA
  • Pace Analytical Services, Inc.
  • Sartorius AG
  • SGS SA
  • Source BioScience PLC
  • Thermo Fisher Scientific, Inc.
  • Toxikon Corporation
  • WuXi AppTec
Frequently Asked Questions about the Global Market for Biologics Safety Testing

What is the estimated value of the Global Market for Biologics Safety Testing?

The Global Market for Biologics Safety Testing was estimated to be valued at $1.9 Billion in 2020.

What is the growth rate of the Global Market for Biologics Safety Testing?

The growth rate of the Global Market for Biologics Safety Testing is 8.2%, with an estimated value of $3.3 Billion by 2027.

What is the forecasted size of the Global Market for Biologics Safety Testing?

The Global Market for Biologics Safety Testing is estimated to be worth $3.3 Billion by 2027.

Table of Contents


  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession


  • Total Companies Profiled: 46